glp-1 lymphedema Normal BMI early results : r/lipedema Ozempic for Lymphedema or Lipedema?
Description
Compared with placebo, ziltivekimab reduced hsCRP concentrations by up to 92%, prompting the formal cardiovascular outcome trial, ZEUS (NCT05021835)

A gradual, personalized dosing schedule is crucial for comfort, safety, and results

The weight loss, frequency of administration, low risk of hypoglycemia, and mechanism of controlling prandial blood glucose seen with GLP-1 RAs offer many advantages as an alternative to prandial insulin

Q: Do GLP-1 drugs affect the brain

Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease
however, uncertainty persists due to heterogeneity in study design, outcome definitions, and follow-up duration
